Page last updated: 2024-11-02

oxymetazoline and Apnea

oxymetazoline has been researched along with Apnea in 1 studies

Oxymetazoline: A direct acting sympathomimetic used as a vasoconstrictor to relieve nasal congestion. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1251)
oxymetazoline : A member of the class of phenols that is 2,4-dimethylphenol which is substituted at positions 3 and 6 by 4,5-dihydro-1H-imidazol-2-ylmethyl and tert-butyl groups, respectively. A direct-acting sympathomimetic with marked alpha-adrenergic activity, it is a vasoconstrictor that is used (generally as the hydrochloride salt) to relieve nasal congestion.

Apnea: A transient absence of spontaneous respiration.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gopalakrishnan, S1
Sodhi, K1

Other Studies

1 other study available for oxymetazoline and Apnea

ArticleYear
Recurrent Apnea in a Neonate Following Intranasal Oxymetazoline.
    Indian pediatrics, 2016, Volume: 53, Issue:4

    Topics: Apnea; Humans; Infant, Newborn; Infant, Premature; Male; Oxymetazoline; Retrospective Studies; Sympa

2016